Synthonics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Synthonics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10612
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Synthonics Inc (Synthonics) is a pharmaceutical company that discovers, develops and licenses metal coordinated pharmaceuticals. The company uses unique metal coordination chemistry for modifying specific properties of patent-expiring pharmaceuticals. It develops MCP-311, a drug candidate that provides solution to extend the absorption phase of levodopa using the bioadhesive properties of a bismuth-levodopa copolymer. Synthonics’ patent applications include bismuth-containing compounds, coordination polymers, methods for modulating pharmacokinetic properties of biologically active agents, and methods for treating patients; metal coordinated compositions; and coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients. The company works in partnership with other pharmaceutical companies to advance the development of novel drugs. Synthonics is headquartered in Blacksburg, Virginia, the US.

Synthonics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synthonics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Synthonics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synthonics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Synthonics Raises USD0.5 Million in Venture Financing 10
Partnerships 11
Recipharm Enters into Agreement with Synthonics 11
Recipharm Enters Into Co-Promotion Agreement With Synthonics 12
Equity Offering 13
Synthonics Raises USD2 Million in Private Placement of Preferred Shares 13
Synthonics Inc – Key Competitors 14
Synthonics Inc – Key Employees 15
Synthonics Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Synthonics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synthonics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synthonics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Synthonics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synthonics Raises USD0.5 Million in Venture Financing 10
Recipharm Enters into Agreement with Synthonics 11
Recipharm Enters Into Co-Promotion Agreement With Synthonics 12
Synthonics Raises USD2 Million in Private Placement of Preferred Shares 13
Synthonics Inc, Key Competitors 14
Synthonics Inc, Key Employees 15

List of Figures
Synthonics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synthonics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synthonics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Synthonics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sheraton Seoul Palace:企業の戦略・SWOT・財務分析
    Sheraton Seoul Palace - Strategy, SWOT and Corporate Finance Report Summary Sheraton Seoul Palace - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • IntelliCell BioSciences Inc:企業の戦略的SWOT分析
    IntelliCell BioSciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Swietelsky Baugesellschaft mbH:企業の戦略的SWOT分析
    Swietelsky Baugesellschaft mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • William Hill PLC:企業の戦略・SWOT・財務情報
    William Hill PLC - Strategy, SWOT and Corporate Finance Report Summary William Hill PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Prakash Constrowell Limited:企業の戦略・SWOT・財務分析
    Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report Summary Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • FuelCell Energy Inc (FCEL):企業の財務・戦略的SWOT分析
    FuelCell Energy Inc (FCEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Xeikon N.V.:企業の戦略的SWOT分析
    Xeikon N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Saponia d.d.:企業の戦略・SWOT・財務情報
    Saponia d.d. - Strategy, SWOT and Corporate Finance Report Summary Saponia d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Seminole Electric Cooperative, Inc.:発電所・企業SWOT分析
    Seminole Electric Cooperative, Inc. – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Albireo Pharma Inc (ALBO)-製薬・医療分野:企業M&A・提携分析
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., is a specialty biopharmaceutical company that focuses on the development and commercialization of innovative bile acid modulators for the treatment of orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and d …
  • Alfa Laval AB (ALFA):企業の財務・戦略的SWOT分析
    Alfa Laval AB (ALFA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Howmet Aerospace Inc (HWM):企業の財務・戦略的SWOT分析
    Howmet Aerospace Inc (HWM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Avista Corp (AVA):企業の財務・戦略的SWOT分析
    Avista Corp (AVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Dominium S.A.:企業の戦略・SWOT・財務情報
    Dominium S.A. - Strategy, SWOT and Corporate Finance Report Summary Dominium S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Nippon Yusen Kabushiki Kaisha:企業の戦略・SWOT・財務情報
    Nippon Yusen Kabushiki Kaisha - Strategy, SWOT and Corporate Finance Report Summary Nippon Yusen Kabushiki Kaisha - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Vycor Medical Inc (VYCO):企業の財務・戦略的SWOT分析
    Summary Vycor Medical Inc (Vycor) is a medical device company that develops, designs, and markets medical devices for use in neurosurgery. The company offers computer-based light stimulation therapies for patients suffering from vision loss resulting from neurological trauma such as stroke. It provi …
  • Kin and Carta plc (KCT):企業の財務・戦略的SWOT分析
    Kin and Carta plc (KCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • South Egypt Drug Industries Co:企業の戦略的SWOT分析
    South Egypt Drug Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • ALS Ltd (ALQ):石油・ガス:M&Aディール及び事業提携情報
    Summary ALS Limited (ALS), formerly, Campbell Brothers Limited is a diversified testing service provider. The company provides testing services in the areas of minerals, life sciences, energy and industrial. It provides offers chemical and laboratory services, technical testing and inspection servic …
  • Latvenergo AS-エネルギー分野:企業M&A・提携分析
    Summary Latvenergo AS (Latvenergo) is a state-owned power supply utility company that generates and supplies electricity and thermal energy, distributes electricity, leases transmission system assets. It generates electricity through various renewable energy sources such as hydropower, biomass, wind …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆